MAPs for PrEP: Dissolving Microarray Patches (MAPs) for Long-acting HIV and Pregnancy Prevention
PATH and its partners are in the early stages of developing microarray patches (MAPs) containing cabotegravir for HIV pre-exposure prophylaxis (PrEP), as well as a MAP containing cabotegravir and a contraceptive—a multipurpose protection technology (MPT).
Publication date: February 2018
MAPs for PrEP: Dissolving Microarray Patches (MAPs) for Long-acting HIV and Pregnancy Prevention516.7 KB PDF
Hard copies are available.